Medtronic gets FDA approval for spinal cord stimulation platform

Medtronic received FDA approval for its spinal cord stimulator, Vanta.

Advertisement

Vanta is a rechargeable-free stimulator and can be optimized for up to 11 years, according to a June 10 news release. It uses Medtronic’s proprietary AdaptiveStim technology for custom pain relief.

Vanta also works with Medtronic’s CareGuidePro app. It allows patients and physicians to monitor spinal cord stimulation outcomes and was launched in May.

At the Becker’s 32nd Annual Meeting: The Business and Operations of ASCs, taking place October 29-31 in Chicago, ASC leaders, surgeons and healthcare executives will explore strategies to drive growth, enhance operational performance, navigate reimbursement challenges and prepare for the future of ambulatory surgery. Apply for complimentary registration now.

Register to Attend Webinar

Is ambulatory care healthcare’s big margin engine? 4 leaders weigh in

Wednesday, July 29
1:00 PM - 2:00 PM CDT

Presenters: Joe Ganley, athenahealthJeffrey Flynn, CASC, Gramercy Surgery CenterBryan Tsao, Access Center, Loma Linda University HealthJason Zepeda, Northridge Hospital Medical Center, CommonSpirit HealthGreg DeConciliis, PA-C, CASC, Boston Out­Patient Surgical Suites

Advertisement

Next Up in Outpatient Spine

Advertisement

Comments are closed.